Agomab to Participate in Upcoming Investor Conferences
Globe Newswire•04/11/2026•16:05 ET
0
Key Highlights
- ➤Agomab management to participate in four upcoming healthcare investor conferences
- ➤Guggenheim fireside chat scheduled for November 10, 2026, in Boston
- ➤Jefferies Global Healthcare Conference participation scheduled for November 18, 2026, in London
- ➤Evercore and Piper Sandler fireside chats scheduled for December 1 and 3, 2026
Antwerp, Belgium, November 4, 2026 – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today announced that members of the management team will participate in the following upcoming investor conferences: * Guggenheim 3rd Annual Healthcare Conference. Fireside chat on Tuesday, November 10, 2026 at 3:30 PM ET in Boston, MA.
* 2026 Jefferies Global Healthcare Conference. Wednesday, November 18, 2026 in London, UK.
Get started
Create a free account to read the full story.